Can we predict and take a proper treatment for postpartum pulmonary embolism? A single institution review of five cases

Abstract

Can we predict and take a proper treatment for postpartum pulmonary embolism? A single institution review of five cases Soo-Ho Chung1 , Chang Woo Choi2 , Jae Hong Sang1, * 1Department of Obstetrics and Gynecology, Soonchunhyang University College of Medicine, 870-1192 Bucheon, Korea 2Department of Thoracic and cardiovascular surgery, Soonchunhyang University College of Medicine, 870-1192 Bucheon, Korea *Correspondence: 77215@schmc.ac.kr (Jae Hong Sang) DOI:10.31083/j.ceog.2021.01.2174 This is an open access article under the CC BY 4.0 license (https://creativecommons.org/licenses/by/4.0/). Submitted: May 30, 2020 Revised: July 14, 2020 Accepted: August 10, 2020 Published: February 15, 2021 Postpartum pulmonary embolism (PPE) is a rare disorder in the puerperium that can present a wide range of symptoms aȻter childbirth. This condition can lead to death and is the most common cause of maternal mortality, accounting for about 10% of all maternal deaths in the United States. A previous study conducted over 3 years (2014- 2016) followed five patients diagnosed with postpartum pulmonary embolism, two of whom died. As PPE is characterized by a variety of symptoms, patients suspected of this condition require prompt diagnosis and treatment. Based on the previous investigation of five patients, the present study aimed to elucidate considerations for early treatment and diagnosis. Maternal mortality can be minimized by proper treatment and early detection using contrast-enhanced chest computerized tomography and echocardiography in women during or aȻter delivery, particularly those with suspected embolism. Keywords Postpartum; Pulmonary embolism; Deep vein thrombosis